BEUDAMED
    FDA Adverse Event Injury Summary report: N

    SILK BLK 10X30IN 0 NON NDL

    MDR report key: 23848316 · Received December 19, 2025

    Report

    Report Number
    2210968-2025-14302
    Event Type
    Injury
    Date Received
    December 19, 2025
    Date of Event
    October 12, 2025
    Report Date
    December 19, 2025
    Manufacturer
    ETHICON INC.
    Product Code
    GAP
    UDI-DI
    10705031050297
    PMA / PMN Number
    K946173
    Adverse Event
    Yes
    Report Source
    Manufacturer report
    Reporter Location
    CH
    Reporter Occupation
    OTHER

    Narratives

    Additional Manufacturer Narrative · 0

    PRODUCT COMPLAINT #(B)(4) THIS REPORT IS BEING SUBMITTED PURSUANT TO THE PROVISIONS OF 21 CFR, PART 803. THIS REPORT MAY BE BASED ON INFORMATION WHICH HAS NOT BEEN INVESTIGATED OR VERIFIED PRIOR TO THE REQUIRED REPORTING DATE. THIS REPORT DOES NOT REFLECT A CONCLUSION BY ETHICON INC, OR ITS EMPLOYEES THAT THE REPORT CONSTITUTES AN ADMISSION THAT THE PRODUCT, ETHICON INC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE POTENTIAL EVENT DESCRIBED IN THIS REPORT. IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL REPORT, A FOLLOW-UP REPORT WILL BE FILED AS APPROPRIATE. A MANUFACTURING RECORD EVALUATION WAS PERFORMED FOR THE FINISHED DEVICE LOT NUMBER, AND NO RELATED NON-CONFORMANCES WERE IDENTIFIED. TO DATE THE DEVICE HAS NOT BEEN RETURNED. IF THE DEVICE OR FURTHER DETAILS ARE RECEIVED AT A LATER DATE A SUPPLEMENTAL MEDWATCH WILL BE SENT. ATTEMPTS ARE BEING MADE TO OBTAIN THE FOLLOWING INFORMATION. TO DATE NO RESPONSE HAS BEEN PROVIDED. IF FURTHER DETAILS ARE RECEIVED AT A LATER DATE A SUPPLEMENTAL MEDWATCH WILL BE SENT: PLEASE PROVIDE THE PATIENT'S DEMOGRAPHIC INFORMATION INCLUDING AGE, GENDER, WEIGHT, BMI AT THE TIME OF INDEX PROCEDURE ON WHAT TISSUE WAS THE SUTURE USED? WHAT WAS THE TISSUE CONDITION (NORMAL, THIN, CALCIFIED, FRAGILE, DISEASED)? HOW WAS THE SUTURE PLACED (INTERRUPTED OR CONTINUOUS)? HOW WAS THE SUTURE ORIGINALLY TIED (MULTIPLE KNOTS, SQUARE KNOT, ETC.)? DID THE OPERATING SURGEON OBSERVE ANY SUTURE DEFICIENCY OR ANOMALY BEFORE, DURING, AFTER THE SUTURE PLACEMENT OR DURING ANY RE-OPERATION? DID THE PATIENT HAVE AN INFECTION? WERE THERE ANY PRE-EXISTING SIGNS/SYMPTOMS OF ACTIVE INFECTION OR INFLAMMATION PRIOR TO THIS SURGICAL PROCEDURE? DID THE PATIENT RECEIVE ANY PROPHYLACTIC ANTIBIOTICS PRE-, INTRA- OR POST-OPERATION? WERE CULTURES AND SENSITIVITIES PERFORMED? IF SO, PLEASE PROVIDE THE RESULTS. PLEASE DESCRIBE ANY MEDICAL INTERVENTION PERFORMED INCLUDING MEDICATION NAME AND RESULTS. WERE ANY PRE-OP CLEANSING PROCEDURES CHANGED RECENTLY? IF YES, PLEASE DESCRIBE OTHER RELEVANT PATIENT HISTORY/CONCOMITANT MEDICATIONS? WHAT IS THE PHYSICIAN¿S OPINION AS TO THE ETIOLOGY OF OR CONTRIBUTING FACTORS TO THIS EVENT? WHAT IS THE PATIENT'S CURRENT STATUS?

    Description of Event or Problem · 0

    IT WAS REPORTED THAT A PATIENT UNDERWENT UPPER AND LOWER LIP SURGERY ON (B)(6) 2025 DUE TO TRAUMA AND SUTURE WAS USED. AFTER ADMISSION, ROUTINE DISINFECTION AND TOWEL LAYING WERE PERFORMED, AND THE WOUND WAS WASHED WITH HYDROGEN PEROXIDE AND 0.9% SALINE SOLUTION TO REMOVE NECROTIC TISSUE AND FOREIGN OBJECTS. LOCAL ANESTHESIA WAS PERFORMED WITH 5ML LIDOCAINE INJECTION. AFTER ANESTHESIA, THE ORIGINAL SKIN WOUNDS OF THE UPPER AND LOWER LIPS WERE TAKEN, AND THE UPPER AND LOWER LIP WOUNDS WERE SUTURED LAYER BY LAYER WITH SUTURES. THE SUTURING WAS SUCCESSFUL, WITH A TOTAL OF 26 STITCHES. INTRAOPERATIVE BLEEDING OF 20 MILLILITERS, POSTOPERATIVE PATIENT SAFELY RETURNED TO THE WARD. ON THE 4TH DAY AFTER SURGERY, IT WAS FOUND THAT THE PATIENT HAD YELLOW LIQUID SECRETION OOZING OUT FROM 6 SUTURE ENDS, AND THERE WAS REDNESS AND INFLAMMATION AT THE SKIN CONTACT AREA OF THE SUTURE ENDS. IT WAS CONSIDERED THAT THE SUTURE END REACTION CAUSED INFECTION. THE DOCTOR IMMEDIATELY RINSED THE WOUND WITH 3% HYDROGEN PEROXIDE DISINFECTANT AND DISINFECTED IT WITH IODINE SOLUTION TWICE A DAY, INSTRUCTING THE PATIENT TO KEEP THE WOUND DRY. ON THE 7TH DAY AFTER SURGERY, IT WAS FOUND THAT THERE WAS STILL SECRETION. CONSIDERING THE HEALING OF THE PATIENT'S WOUND, THE SUTURE AT THE INFECTED SITE WAS REMOVED AND RINSED WITH 3% HYDROGEN PEROXIDE DISINFECTANT AND DISINFECTED WITH IODINE SOLUTION ONCE A DAY. ERYTHROMYCIN OINTMENT WAS APPLIED TOPICALLY. ON THE 10TH DAY AFTER SURGERY, THERE WAS NO EXUDATE AT THE COMPRESSED WOUND SITE, AND THE WOUND HEALED WELL WITHOUT ANY OTHER DISCOMFORT. ADDITIONAL INFORMATION WAS REQUESTED.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    257522 SILK BLK 10X30IN 0 NON NDL SUTURE, NONABSORBABLE, SILK GAP ETHICON INC. XC3AE 10705031050297

    Patients

    Seq Age Sex Outcome Treatment
    1 NA Unknown Required Intervention